Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.
Clin Transl Radiat Oncol
; 37: 71-77, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-36093343
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Aspects:
Patient_preference
Language:
En
Journal:
Clin Transl Radiat Oncol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: